Cargando…
T-cell subset changes during the first year of pre-seasonal allergoid allergen-specific immunotherapy
Allergen-specific immunotherapy (AIT) is the only treatment for type I allergy, which achieves long-lasting effects. Repeated subcutaneous applications of allergen extracts cause a protective antibody response and an immune deviation of T cells. In AIT with allergoids, chemically modified allergen e...
Autores principales: | Reithofer, Manuel, Boell, Simone Lisa, Kitzmueller, Claudia, Horak, Fritz, Bohle, Barbara, Jahn-Schmid, Beatrice |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10685201/ https://www.ncbi.nlm.nih.gov/pubmed/38034768 http://dx.doi.org/10.1016/j.heliyon.2023.e21878 |
Ejemplares similares
-
Alum‐adjuvanted allergoids induce functional IgE‐blocking antibodies
por: Reithofer, M., et al.
Publicado: (2018) -
Adjuvants and Vaccines Used in Allergen-Specific Immunotherapy Induce Neutrophil Extracellular Traps
por: Karacs, Jasmine, et al.
Publicado: (2021) -
Allergens with Protease Activity from House Dust Mites
por: Reithofer, Manuel, et al.
Publicado: (2017) -
484 Allergen Standardisation in Allergens and Allergoids—Challenges and Considerations
por: Skinner, Murray, et al.
Publicado: (2012) -
Sublingual immunotherapy with recombinant Mal d 1 downregulates the allergen‐specific Th2 response
por: Kitzmüller, Claudia, et al.
Publicado: (2019)